Cargando…

The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review

Norepinephrine (NE) is recognized as having a key role in the pathophysiology of major depressive disorder (MDD) and schizophrenia, although its distinct actions via α-adrenergic receptors (α-ARs) are not well defined. We performed a systematic review examining the roles of NE and α-ARs in MDD and s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maletic, Vladimir, Eramo, Anna, Gwin, Keva, Offord, Steve J., Duffy, Ruth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355451/ https://www.ncbi.nlm.nih.gov/pubmed/28367128 http://dx.doi.org/10.3389/fpsyt.2017.00042

Ejemplares similares

The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies
por: Weiss, Catherine, et al.
Publicado: (2018)

Machine Learning-Based Electroencephalographic Phenotypes of Schizophrenia and Major Depressive Disorder
por: Jang, Kuk-In, et al.
Publicado: (2021)

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
por: Karson, Craig, et al.
Publicado: (2016)

Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder
por: Yang, Yongfeng, et al.
Publicado: (2019)

Identification of Key Genes and the Pathophysiology Associated With Major Depressive Disorder Patients Based on Integrated Bioinformatics Analysis
por: Zhang, Guangyin, et al.
Publicado: (2020)

Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders
por: Murray, Alex J., et al.
Publicado: (2021)

Shared and distinct functional connectivity of hippocampal subregions in schizophrenia, bipolar disorder, and major depressive disorder
por: Song, Yanzhuo, et al.
Publicado: (2022)

The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Zhu, Yue, et al.
Publicado: (2019)

Volumes of hippocampal subfields suggest a continuum between schizophrenia, major depressive disorder and bipolar disorder
por: Cao, Peiyu, et al.
Publicado: (2023)

Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
por: Sonnenschein, Susan F., et al.
Publicado: (2020)

Neuroimaging as a Window Into the Pathophysiological Mechanisms of Schizophrenia
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2021)

Evidence for Schizophrenia-Specific Pathophysiology of Nicotine Dependence
por: Ward, Heather Burrell, et al.
Publicado: (2022)

Advances in the knowledge and therapeutics of schizophrenia, major depression disorder, and bipolar disorder from human brain organoid research
por: Villanueva, Rosa
Publicado: (2023)

Integrated Neurobiology of Bipolar Disorder
por: Maletic, Vladimir, et al.
Publicado: (2014)

Subcortical Brain Volumes Relate to Neurocognition in First-Episode Schizophrenia, Bipolar Disorder, Major Depression Disorder, and Healthy Controls
por: Shi, Jing, et al.
Publicado: (2022)

Aggressive and Disruptive Behavior Among Psychiatric Patients With Major Depressive Disorder, Schizophrenia, or Alcohol Dependency and the Effect of Depression and Self-Esteem on Aggression
por: Fritz, Michael, et al.
Publicado: (2020)

Prefrontal Cortex Activation During Verbal Fluency Task and Tower of London Task in Schizophrenia and Major Depressive Disorder
por: Xiang, Yilei, et al.
Publicado: (2021)

Common and Distinct Alterations of Cognitive Function and Brain Structure in Schizophrenia and Major Depressive Disorder: A Pilot Study
por: Ma, Mengying, et al.
Publicado: (2021)

Inflexibility in Reasoning: Comparisons of Cognitive Flexibility, Explanatory Flexibility, and Belief Flexibility Between Schizophrenia and Major Depressive Disorder
por: Zhu, Chen, et al.
Publicado: (2021)

Comparing the Self-Reported Personality Disorder Traits and Childhood Traumatic Experiences Between Patients With Schizophrenia Vs. Major Depressive Disorder
por: Zhao, Nan, et al.
Publicado: (2021)

Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function
por: Yu, Hua, et al.
Publicado: (2023)

Lipidomics in Major Depressive Disorder
por: Walther, Andreas, et al.
Publicado: (2018)

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment
por: Yao, Lin, et al.
Publicado: (2020)

Reduced Plasma Levels of α-Klotho and Their Correlation With Klotho Polymorphisms in Elderly Patients With Major Depressive Disorders
por: Gao, Xiang, et al.
Publicado: (2021)

The pathophysiology and management of depression in cardiac surgery patients
por: Vu, Tony, et al.
Publicado: (2023)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Batinic, Borjanka, et al.
Publicado: (2021)

Relevance of Norepinephrine–Dopamine Interactions in the Treatment of Major Depressive Disorder
por: El Mansari, Mostafa, et al.
Publicado: (2010)

Schizophrenia and Hereditary Polyneuropathy: PMP22 Deletion as a Common Pathophysiological Link?
por: Endres, Dominique, et al.
Publicado: (2019)

Unraveling the pathophysiology of schizophrenia: insights from structural magnetic resonance imaging studies
por: Adamu, Mohammed Jajere, et al.
Publicado: (2023)

Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study Protocol
por: Bilderbeck, Amy C., et al.
Publicado: (2020)

Circular RNA in Schizophrenia and Depression
por: Li, Zexuan, et al.
Publicado: (2020)

Eye Movement Abnormalities in Major Depressive Disorder
por: Takahashi, Junichi, et al.
Publicado: (2021)

Cortical Inhibition and Plasticity in Major Depressive Disorder
por: Castricum, Jesminne, et al.
Publicado: (2022)

The roles of extracellular vesicles in major depressive disorder
por: Li, Ying, et al.
Publicado: (2023)

Identifying circulating biomarkers for major depressive disorder
por: Zhang, En, et al.
Publicado: (2023)

Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression
por: Tang, Yiguo, et al.
Publicado: (2021)

SIGIRR and TNFAIP3 Are Differentially Expressed in Both PBMC and TNF-α Secreting Cells of Patients With Major Depressive Disorder
por: Lin, Chin-Chuen, et al.
Publicado: (2021)

Exploration of Major Cognitive Deficits in Medication-Free Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2019)

The Role of Chemokines in the Pathophysiology of Major Depressive Disorder
por: Milenkovic, Vladimir M., et al.
Publicado: (2019)

Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression
por: Zhang, Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rfgomdl9vs7btatvtujr2dhlrg